Targeted Therapy for Pulmonary Hypertension in Premature Infants

• Egile Nagusiak: Shannon N. Nees (Egilea), Erika B. Rosenzweig (Egilea), Jennifer L. Cohen (Egilea), Gerson A. Valencia Villeda (Egilea), Usha S. Krishnan (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Pulmonary hypertension (PH) is common in premature infants with bronchopulmonary dysplasia (BPD) and is associated with significant mortality. Despite expert consensus suggesting the use of targeted therapies such as phosphodiesterase inhibitors, endothelin receptor antagonists, and prostanoids, the...